Key result
Surgical treatment of prosthetic valve endocarditis did not significantly reduce overall mortality compared to medical therapy (17% vs 25%), but improved outcomes in high-risk subgroups.
Why the study?
Does a surgical strategy improve mortality in patients with prosthetic valve endocarditis compared to medical therapy?
Observational (n=104)
Yes
Does a surgical strategy improve mortality in patients with prosthetic valve endocarditis compared to medical therapy?
Absolute Event Rate: 17% vs 25%
p-value: p=not significant
While surgery does not significantly reduce mortality in all patients with prosthetic valve endocarditis, it is associated with better outcomes in high-risk subgroups, specifically those with staphylococcal infection and complicated PVE.
No takes yet. Share an insight, caveat, or question.
Does not support routine surgery over medical therapy for prosthetic valve endocarditis; leaves open targeted benefit in high-risk subgroups.
G. Habib (2005) conducted an observational in Prosthetic valve endocarditis (n=104). Surgical strategy vs. Non-surgical (medical) strategy was evaluated on Mortality (p=not significant). Surgical treatment of prosthetic valve endocarditis did not significantly reduce overall mortality compared to medical therapy (17% vs 25%), but improved outcomes in high-risk subgroups.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: